Thank you to our speakers, sponsors, and delegates who joined us in Boston for the 2nd Annual PAT & Real Time Quality Summit 2023! If you are interested in the 2024 event, please get in touch at email@example.com
The 2nd Annual PAT & Real Time Quality Summit 2023
With drug developers and manufacturers facing closer scrutiny on product quality than ever before, it’s time to make the most of evolving process analytical technology to design robust and cost-effective control strategies and understand more about your biopharmaceutical products.
The likes of Bristol Myers Squibb, Vertex, Moderna, Sanofi and Novo Nordisk and more united in December 2023 for the 2nd PAT & Real Time Quality Summit to revolutionize real-time quality strategies across a wide range of novel modality applications, and share advances in machine learning that are making real-time control and diversion a reality.
Whilst the sector is still battling with justifying investment and integration, the summit demonstrates tangible return on investment for process analytical technology in drug development and GMP environments, through increased yield, inline and online monitoring, predictive modelling, and accelerated speed to market.
60+ PAT experts joined us, including process development, analytical development, MSAT directors, and chemometricians; for the one and only end-to-end playbook for the successful advancement, integration, and adoption of process analytical technology in highly regulated pharmaceutical environments.
2023 World-Class Speaker Faculty:
Previously Attending Companies Include:
What People Say About Our Events
"Being a newcomer to the pharma industry, it was a great opportunity for me to see the efforts being made in the area of PAT and real time analysis and listen to the experts who are working on the forefront."
Research Scientist, Gilead Sciences
"It was amazing that the speakers were among the attendees and very accessible. The intimacy of the event made for really open communication and networking opportunities."
Process Engineer, Sanofi
"This was a very unique experience with opportunity to work in small groups and lead fruitful discussions. The size of the summit was a huge advantage and made this experience stand out".
Senior Scientist, Sangamo Therapeutics